rs4295627
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 1.61 | 1.85x higher risk for glioma development |
| (G;T) | 1.3 | 1.36x higher risk for glioma development |
| (T;T) | 0 |
| Reference | GRCh38 38.1/141 |
| Chromosome | 8 |
| Position | 129673211 |
| Gene | CCDC26 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs4295627 |
| dbSNP (classic) | rs4295627 |
| ClinGen | rs4295627 |
| ebi | rs4295627 |
| HLI | rs4295627 |
| Exac | rs4295627 |
| Gnomad | rs4295627 |
| Varsome | rs4295627 |
| LitVar | rs4295627 |
| Map | rs4295627 |
| PheGenI | rs4295627 |
| Biobank | rs4295627 |
| 1000 genomes | rs4295627 |
| hgdp | rs4295627 |
| ensembl | rs4295627 |
| geneview | rs4295627 |
| scholar | rs4295627 |
| rs4295627 | |
| pharmgkb | rs4295627 |
| gwascentral | rs4295627 |
| openSNP | rs4295627 |
| 23andMe | rs4295627 |
| SNPshot | rs4295627 |
| SNPdbe | rs4295627 |
| MSV3d | rs4295627 |
| GWAS Ctlg | rs4295627 |
| GMAF | 0.202 |
| Max Magnitude | 1.61 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
23andMe blog rs4295627 G 1.36 Glioma
| GWAS snp | |
|---|---|
| PMID | [PMID 19578367 ]
|
| Trait | Glioma |
| Title | Genome-wide association study identifies five susceptibility loci for glioma |
| Risk Allele | G |
| P-val | 2E-18 |
| Odds Ratio | 1.36 [1.29-1.43] |
[PMID 20462933] Interaction between 5 genetic variants and allergy in glioma risk
[PMID 20847058] Genetic risk profiles identify different molecular etiologies for glioma
[PMID 20211558] Genetic advances in glioma: susceptibility genes and networks
| GWAS snp | |
|---|---|
| PMID | [PMID 21531791]
|
| Trait | |
| Title | Chromosome 7p11.2 (EGFR) variation influences glioma risk. |
| Risk Allele | |
| P-val | 5E-21 |
| Odds Ratio | 1.4000 [NR] |
[PMID 20212223] New insights into susceptibility to glioma.
[PMID 21356187] Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
[PMID 21825990] Genetic causes of glioma: new leads in the labyrinth.
[PMID 23161787] Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies
[PMID 26243184] An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk
[PMID 26505354] CCDC26 rs4295627 polymorphism (8q24.21) and glioma risk: a meta-analysis
